Metabolic Disease Oncology Inflammation CNS Cardiovascular Partners
 
 
     
  Plexxikon has raised approximately $67 million to date in three venture rounds, led by a group of highly experienced and well-regarded biotechnology investors.

Series C: $12.5 million - September 2006
Series B: $46.25 million -April 2002-April 2004
Series A: $8.2 million - May 2001

Investors
Advanced Technology Ventures (ATV)
Alta Partners
Astellas Venture Capital
CW Ventures
GIMV
Kumho Asiana Group
NIF SMBC Ventures
Pappas Ventures
Walden International

Investor Contact
C. Fletcher Payne
Vice President and Chief Financial Officer
Phone: 510.647.4101
Fax: 510.548.8014
fpayne@plexxikon.com
 
     
 
Metabolic Disease | Oncology | Inflammation | CNS | Cardiovascular | Partners
Home | About Plexxikon | Investors | News | Clinical Trials | Careers | Contact Us | Site Map
© 2007 Plexxikon Inc. | Site design by Heiney & Craig